Cure Pharmaceutical Holding Corp. (IFIN)
NYSE
Closed
Aug 21, 2026
Day's Range
3.4552 wk Range
1.31Profile - IFIN - Cure Pharmaceutical Holding Corp.
Profile
Mic Code
XNYS
Sector
Technology
Industry
Software - Application
Employees
244
Cure Pharmaceutical Holding Corp. is a biopharmaceutical company focused on the development and commercialization of innovative drug delivery systems. It aims to improve patient adherence and experience by providing new methods for drug delivery, such as oral thin films and transdermal systems. Cure Pharmaceutical's technologies are designed to enhance the bioavailability, efficacy, and safety of existing pharmaceutical compounds while also providing a platform for new drug formulations. This plays a vital role in several therapeutic areas, including pain management, oncology, and central nervous system disorders. By leveraging cutting-edge technology and partnerships within the pharmaceutical industry, Cure Pharmaceutical Holding Corp. contributes to the advancement of personalized and precision medicine, addressing unmet medical needs and broadening the spectrum of delivery options in healthcare markets.
Profile Details
Type
Common Stock
Ceo
Mr. King Ong Kong
Address
410 North Bridge Road
City
Singapore
State
NY
Zip
188726
Country
Singapore
Phone
65 6407 7362
Key Executives - IFIN - Cure Pharmaceutical Holding Corp.
Key executives
Cross Listings - IFIN - Cure Pharmaceutical Holding Corp.
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
